Life-threatening altered mental status secondary to memantine in an adolescent undergoing cranial radiotherapy for medulloblastoma.

Kristine N KimYash B ShahColleen CroyRobert A LustigMichael LaRiviereChelsea Kotch

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)

Clinicians should be aware of and consider the risk of altered mental status with memantine, given the increased utilization and upcoming clinical trials in pediatric patients.

Keyphrases

mental health
clinical trial
young adults
early stage
radiation therapy
palliative care
locally advanced
radiation induced